Advertisement
Screener

AGIOS PHARMACEUTICALS, INC. (AGIO) Pre-Tax Margin

AGIOS PHARMACEUTICALS, INC. (AGIO) Pre-Tax Margin

  • 2025-12-31: Pre-Tax Margin -546.18%.
  • 2025-09-30: Pre-Tax Margin -803.05%.
  • 2024-12-31: Pre-Tax Margin -982.28%.
  • 2024-09-30: Pre-Tax Margin 11167.28%.

Complete source-backed pre-tax margin history.

Available history
2011-12-31 to 2025-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-546.18%
2025-09-30-803.05%
2024-12-31-982.28%
2024-09-3011167.28%
2023-12-31-1350.70%
2023-09-30-1234.27%
2014-06-30-217.81%
2014-03-31-145.81%
2013-12-31-181.09%
2013-09-30-176.39%
2013-06-30-135.25%
2013-03-31-111.71%
2012-12-31-103.30%
2012-09-30-81.32%
2012-06-30-97.03%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-765.89%
2024-12-311967.15%
2023-12-31-1312.63%
2022-12-31-1627.82%
2019-12-31-255.62%
2018-12-31-366.61%
2017-12-31-731.60%
2016-12-31-283.97%
2015-12-31-199.14%
2014-12-31-82.51%
2013-12-31-151.98%
2012-12-31-91.32%
2011-12-31-75.56%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Zymeworks Inc. (ZYME)United States$1.902B-12.44
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Generate Biomedicines, Inc. (GENB)United States$2.052B
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55